148 related articles for article (PubMed ID: 38042585)
1. How B cells drive T-cell responses: A key role for cross-presentation of antibody-targeted antigens.
Ossendorp F; Ho NI; Van Montfoort N
Adv Immunol; 2023; 160():37-57. PubMed ID: 38042585
[TBL] [Abstract][Full Text] [Related]
2. Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.
Hotblack A; Seshadri S; Zhang L; Hamrang-Yousefi S; Chakraverty R; Escors D; Bennett CL
Mol Ther; 2017 Feb; 25(2):504-511. PubMed ID: 28153097
[TBL] [Abstract][Full Text] [Related]
3. A novel recycling mechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentation.
Engeroff P; Fellmann M; Yerly D; Bachmann MF; Vogel M
J Allergy Clin Immunol; 2018 Aug; 142(2):557-568.e6. PubMed ID: 29074459
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation.
Steinman RM
Mt Sinai J Med; 2001 May; 68(3):160-6. PubMed ID: 11373688
[TBL] [Abstract][Full Text] [Related]
5. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.
Schnurr M; Chen Q; Shin A; Chen W; Toy T; Jenderek C; Green S; Miloradovic L; Drane D; Davis ID; Villadangos J; Shortman K; Maraskovsky E; Cebon J
Blood; 2005 Mar; 105(6):2465-72. PubMed ID: 15546948
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins.
Fessenden TB; Stopfer LE; Chatterjee F; Zulueta J; Mesfin J; Cordero Dumit T; Reijers I; Hoefsmit EP; Blank C; White F; Spranger S
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35820727
[TBL] [Abstract][Full Text] [Related]
7. Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine.
Schuurhuis DH; van Montfoort N; Ioan-Facsinay A; Jiawan R; Camps M; Nouta J; Melief CJ; Verbeek JS; Ossendorp F
J Immunol; 2006 Apr; 176(8):4573-80. PubMed ID: 16585547
[TBL] [Abstract][Full Text] [Related]
8. Distinct antigen uptake receptors route to the same storage compartments for cross-presentation in dendritic cells.
Ho NI; Camps MG; Garcia-Vallejo JJ; Bos E; Koster AJ; Verdoes M; van Kooyk Y; Ossendorp F
Immunology; 2021 Nov; 164(3):494-506. PubMed ID: 34110622
[TBL] [Abstract][Full Text] [Related]
9. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.
Sánchez-Paulete AR; Teijeira A; Cueto FJ; Garasa S; Pérez-Gracia JL; Sánchez-Arráez A; Sancho D; Melero I
Ann Oncol; 2017 Dec; 28(suppl_12):xii44-xii55. PubMed ID: 28945841
[TBL] [Abstract][Full Text] [Related]
10. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
11. Immune complex-mediated antigen presentation induces tumor immunity.
Rafiq K; Bergtold A; Clynes R
J Clin Invest; 2002 Jul; 110(1):71-9. PubMed ID: 12093890
[TBL] [Abstract][Full Text] [Related]
12. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
[TBL] [Abstract][Full Text] [Related]
13. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
Ho NI; Camps MGM; de Haas EFE; Ossendorp F
Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies targeted against melanoma and ovarian tumors enhance dendritic cell-mediated cross-presentation of tumor-associated antigens and efficiently cross-prime CD8+ T cells.
Cioca DP; Deak E; Cioca F; Paunescu V
J Immunother; 2006; 29(1):41-52. PubMed ID: 16365599
[TBL] [Abstract][Full Text] [Related]
15. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
Montealegre S; van Endert PM
Front Immunol; 2018; 9():3098. PubMed ID: 30666258
[TBL] [Abstract][Full Text] [Related]
16. Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy.
Moussion C; Delamarre L
Semin Immunol; 2024 Feb; 71():101848. PubMed ID: 38035643
[TBL] [Abstract][Full Text] [Related]
17. FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cells.
Boross P; van Montfoort N; Stapels DA; van der Poel CE; Bertens C; Meeldijk J; Jansen JH; Verbeek JS; Ossendorp F; Wubbolts R; Leusen JH
J Immunol; 2014 Dec; 193(11):5506-14. PubMed ID: 25355925
[TBL] [Abstract][Full Text] [Related]
18. C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes.
Ho NI; Camps MGM; de Haas EFE; Trouw LA; Verbeek JS; Ossendorp F
J Immunol; 2017 Jun; 198(11):4235-4243. PubMed ID: 28432146
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
[TBL] [Abstract][Full Text] [Related]
20. Active dissemination of cellular antigens by DCs facilitates CD8
Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
